Back to Screener

Healthcare

CSL Limited Sponsored ADR(CSLLY)

Live Price

Offline

$19.97

-2.35% today

1Y Change

-46.92%

Window

Jun 27, 2025 β†’ Jun 25, 2026

Market Cap
$43.51B
Revenue Growth
+5.0%
EPS Growth
+13.3%
Dividend Yield
3.4%

Coverage: 250 bars Β· Jun 27, 2025 β†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

CSL Limited Sponsored ADR (CSLLY) is a Healthcare stock with a market cap of $43.51B and listed on OTC. The stock last traded around $19.97 and down 46.9% across the available one-year price window (Jun 27, 2025 β†’ Jun 25, 2026). Baseline metrics include revenue growth of +5.0%, EPS growth of +13.3%, a dividend yield of 3.4%. What stands out right now is revenue +5.0%, EPS +13.3%, free cash flow +68.9% with operating margin 19.2% and ROIC 10.4%. The dividend matters to the case here, with a current yield around 3.4%. Valuation already assumes a fairly strong business story at P/E 30.1 and price/sales 2.8. Stock Foundry combines CSLLY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CSLLY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CSLLY

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CSLLY Max Drawdown

-63.25%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CSLLY and SPY.

Calendar-year return history is still loading or unavailable.

Unable to load analyst forecasts.

Timed out loading forecasts for CSLLY

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.